Lynx1 Capital Management’s Allogene Therapeutics ALLO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.5M Hold
11,057,009
3.61% 6
2025
Q1
$16.1M Buy
11,057,009
+182,286
+2% +$266K 5.78% 6
2024
Q4
$23.2M Buy
10,874,723
+4,672,349
+75% +$9.95M 8.68% 5
2024
Q3
$17.4M Buy
6,202,374
+3,974,079
+178% +$11.1M 6.15% 6
2024
Q2
$5.19M Buy
+2,228,295
New +$5.19M 1.87% 7